Roche Holding AG (RO) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.296x

Based on the latest financial reports, Roche Holding AG (RO) has a cash flow conversion efficiency ratio of 0.296x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF11.23 Billion ≈ $14.20 Billion USD) by net assets (CHF37.88 Billion ≈ $47.89 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Roche Holding AG liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Roche Holding AG - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Roche Holding AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Roche Holding AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Roche Holding AG ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Celestica Inc.
TO:CLS
0.170x
Bank Central Asia Tbk
JK:BBCA
0.022x
Danske Bank A/S
CO:DANSKE
-0.020x
STMicroelectronics N.V
F:SGMR
0.029x
Takeda Pharmaceutical Company Limited
F:TKDA
0.049x
Itaú Unibanco Holding S.A
F:BVXB
-0.202x
Ambev S.A.
F:AMNA
0.149x
Fortescue Ltd
AU:FMG
0.156x

Annual Cash Flow Conversion Efficiency for Roche Holding AG (1998–2025)

The table below shows the annual cash flow conversion efficiency of Roche Holding AG from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Roche Holding AG worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CHF37.88 Billion
≈ $47.89 Billion
CHF17.83 Billion
≈ $22.54 Billion
0.471x -15.29%
2024-12-31 CHF36.16 Billion
≈ $45.72 Billion
CHF20.09 Billion
≈ $25.40 Billion
0.556x +14.84%
2023-12-31 CHF33.26 Billion
≈ $42.05 Billion
CHF16.09 Billion
≈ $20.35 Billion
0.484x -15.88%
2022-12-31 CHF32.02 Billion
≈ $40.48 Billion
CHF18.41 Billion
≈ $23.28 Billion
0.575x -22.27%
2021-12-31 CHF28.34 Billion
≈ $35.84 Billion
CHF20.98 Billion
≈ $26.52 Billion
0.740x +58.53%
2020-12-31 CHF39.77 Billion
≈ $50.28 Billion
CHF18.57 Billion
≈ $23.47 Billion
0.467x -25.21%
2019-12-31 CHF35.87 Billion
≈ $45.35 Billion
CHF22.39 Billion
≈ $28.30 Billion
0.624x -5.14%
2018-12-31 CHF30.37 Billion
≈ $38.39 Billion
CHF19.98 Billion
≈ $25.26 Billion
0.658x +5.89%
2017-12-31 CHF29.01 Billion
≈ $36.67 Billion
CHF18.02 Billion
≈ $22.79 Billion
0.621x +9.36%
2016-12-31 CHF26.40 Billion
≈ $33.38 Billion
CHF15.00 Billion
≈ $18.97 Billion
0.568x -13.20%
2015-12-31 CHF23.30 Billion
≈ $29.46 Billion
CHF15.25 Billion
≈ $19.28 Billion
0.655x -11.42%
2014-12-31 CHF21.56 Billion
≈ $27.26 Billion
CHF15.93 Billion
≈ $20.14 Billion
0.739x -0.48%
2013-12-31 CHF21.24 Billion
≈ $26.85 Billion
CHF15.77 Billion
≈ $19.94 Billion
0.743x -17.22%
2012-12-31 CHF16.73 Billion
≈ $21.15 Billion
CHF15.01 Billion
≈ $18.97 Billion
0.897x +0.28%
2011-12-31 CHF14.48 Billion
≈ $18.31 Billion
CHF12.95 Billion
≈ $16.38 Billion
0.894x -27.27%
2010-12-31 CHF11.66 Billion
≈ $14.74 Billion
CHF14.34 Billion
≈ $18.13 Billion
1.230x -31.40%
2009-12-31 CHF9.41 Billion
≈ $11.90 Billion
CHF16.88 Billion
≈ $21.34 Billion
1.793x +692.39%
2008-12-31 CHF53.82 Billion
≈ $68.05 Billion
CHF12.18 Billion
≈ $15.40 Billion
0.226x +2.83%
2007-12-31 CHF53.31 Billion
≈ $67.39 Billion
CHF11.73 Billion
≈ $14.83 Billion
0.220x -0.29%
2006-12-31 CHF46.81 Billion
≈ $59.19 Billion
CHF10.33 Billion
≈ $13.06 Billion
0.221x -7.67%
2005-12-31 CHF41.74 Billion
≈ $52.77 Billion
CHF9.97 Billion
≈ $12.61 Billion
0.239x +8.46%
2004-12-31 CHF33.29 Billion
≈ $42.09 Billion
CHF7.33 Billion
≈ $9.27 Billion
0.220x -11.41%
2003-12-31 CHF29.16 Billion
≈ $36.87 Billion
CHF7.25 Billion
≈ $9.17 Billion
0.249x +552.72%
2002-12-31 CHF25.77 Billion
≈ $32.58 Billion
CHF982.00 Million
≈ $1.24 Billion
0.038x -74.64%
2001-12-31 CHF33.87 Billion
≈ $42.82 Billion
CHF5.09 Billion
≈ $6.43 Billion
0.150x +22.90%
2000-12-31 CHF32.04 Billion
≈ $40.50 Billion
CHF3.92 Billion
≈ $4.95 Billion
0.122x +112.35%
1999-12-31 CHF30.00 Billion
≈ $37.93 Billion
CHF1.73 Billion
≈ $2.18 Billion
0.058x -63.69%
1998-12-31 CHF22.82 Billion
≈ $28.84 Billion
CHF3.62 Billion
≈ $4.57 Billion
0.159x --

About Roche Holding AG

SW:RO Switzerland Drug Manufacturers - General
Market Cap
$43.73 Billion
CHF34.59 Billion CHF
Market Cap Rank
#626 Global
#9 in Switzerland
Share Price
CHF324.20
Change (1 day)
-2.64%
52-Week Range
CHF257.80 - CHF382.20
All Time High
CHF402.61
About

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and tr… Read more